SEC Filing Summary: Intrexon Corporation (Form 8-K)
Business Context and Reporting Period
Company: Intrexon Corporation (Note: Metadata referenced "Precigen, Inc.", but the filing text identifies the registrant as Intrexon Corporation).
Filing Date: December 3, 2015
Reporting Period: Current report covering events as of December 3, 2015.
Context: The filing addresses the resale of shares issued in connection with the acquisition of Oxitec Limited completed in September 2015.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This is a Current Report (Form 8-K) focused on a specific corporate event rather than a periodic financial report.
Material Changes
- Prospectus Supplement Filed: Intrexon filed a prospectus supplement to its registration statement on Form S-3ASR (File No. 333-198598).
- Share Resale: The supplement covers the resale of Intrexon common stock shares issued and to be issued to Oxitec Limited shareholders as part of the September 2015 acquisition.
- Legal Opinion: An opinion from Troutman Sanders LLP regarding the resale was filed as Exhibit 5.1.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of the share resale event.
Investor Verification Checklist
- Verify the details of the Oxitec Limited acquisition completed in September 2015.
- Review the full Prospectus Supplement filed under Form S-3ASR (File No. 333-198598) for terms of the share resale.
- Confirm the legal opinion provided by Troutman Sanders LLP (Exhibit 5.1) regarding the validity of the share issuance.
- Check subsequent filings for any financial impact resulting from the acquisition or share resale.